Seeking Alpha

cposch » Comments » ACTC

  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    Will someone tell this author to do his homework and stop pumping Ariad Pharma. This stock is not a stem-cell stock, but merely a company with a history of massive losses from a CEO who was runner up for "Worst Biotech CEO of 2008."
    Mar 12 10:31 am |Rating: +1 0 |Link to Comment
More on ACTC by cposch
Comments by Ticker
cposch's
Comments Stats
10 comments
Rating: 11 (11 - 0 )